OpenAI introduces GPT-Rosalind for life sciences research

OpenAI has launched GPT-Rosalind, a specialty model for life-sciences research that works across scientific literature and biological data inside Rosalind Workbench. Access is gated and available through ChatGPT, Codex and the API.

• The model synthesizes literature, integrates biological data and helps plan experiments
• GPT-Rosalind access is gated rather than broadly open to all users
• A separate Rosalind Biodefense program offers sponsored access
• Partners include Novo Nordisk, Moderna, Amgen, Thermo Fisher and the Allen Institute